Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

L.B. van de Putte; C. Atkins; M. Malaise; J. Sany; A.S. Russell; P.L. Riel; L. Settas; J.W.J. Bijlsma; S. Todesco; M. Dougados; P. Nash; P. Emery; N. Walter; M. Kaul; S. Fischkoff; H. Kupper

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

Translated title of the contribution: Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

L.B. van de Putte, C. Atkins, M. Malaise, J. Sany, A.S. Russell, P.L. Riel, L. Settas, J.W.J. Bijlsma, S. Todesco, M. Dougados, P. Nash, P. Emery, N. Walter, M. Kaul, S. Fischkoff, H. Kupper

Rheumatology & Clinical Immunology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed
Original language	Undefined/Unknown
Pages (from-to)	508-516
Number of pages	9
Journal	Annals of the Rheumatic Diseases
Volume	63
Issue number	5
Publication status	Published - 2004

Cite this

van de Putte, L. B., Atkins, C., Malaise, M., Sany, J., Russell, A. S., Riel, P. L., Settas, L., Bijlsma, J. W. J., Todesco, S., Dougados, M., Nash, P., Emery, P., Walter, N., Kaul, M., Fischkoff, S., & Kupper, H. (2004). Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Annals of the Rheumatic Diseases, 63(5), 508-516.

@article{01580022f7d84698b4d5ffcb6f78031e,

title = "Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed",

author = "{van de Putte}, L.B. and C. Atkins and M. Malaise and J. Sany and A.S. Russell and P.L. Riel and L. Settas and J.W.J. Bijlsma and S. Todesco and M. Dougados and P. Nash and P. Emery and N. Walter and M. Kaul and S. Fischkoff and H. Kupper",

year = "2004",

language = "Undefined/Unknown",

volume = "63",

pages = "508--516",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "5",

}

van de Putte, LB, Atkins, C, Malaise, M, Sany, J, Russell, AS, Riel, PL, Settas, L, Bijlsma, JWJ, Todesco, S, Dougados, M, Nash, P, Emery, P, Walter, N, Kaul, M, Fischkoff, S & Kupper, H 2004, 'Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed', Annals of the Rheumatic Diseases, vol. 63, no. 5, pp. 508-516.

TY - JOUR

T1 - Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

AU - van de Putte, L.B.

AU - Atkins, C.

AU - Malaise, M.

AU - Sany, J.

AU - Russell, A.S.

AU - Riel, P.L.

AU - Settas, L.

AU - Bijlsma, J.W.J.

AU - Todesco, S.

AU - Dougados, M.

AU - Nash, P.

AU - Emery, P.

AU - Walter, N.

AU - Kaul, M.

AU - Fischkoff, S.

AU - Kupper, H.

PY - 2004

Y1 - 2004

M3 - Article

SN - 0003-4967

VL - 63

SP - 508

EP - 516

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 5

ER -